Filing Details
- Accession Number:
- 0001209191-19-049683
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-09-16 17:28:24
- Reporting Period:
- 2019-09-13
- Accepted Time:
- 2019-09-16 17:28:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1642380 | Oncocyte Corp | OCX | In Vitro & In Vivo Diagnostic Substances (2835) | 271041563 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1786237 | T Tony Kalajian | 1010 Atlantic Avenue, Suite 102 Alameda CA 94501 | Svp-Chief Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, No Par Value | Acquisiton | 2019-09-13 | 10,000 | $1.98 | 10,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price of $1.98 per share represents a weighted average of prices ranging from $1.94 to $1.987 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Billionaire Hedge Funds
